LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

11.5 -2.79

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

11.41

Максимум

11.57

Ключови измерители
By Trading Economics
Приходи	10M -33M
Продажби	-435K 54M
Марж на печалбата	-60.369
Служители	891
EBITDA	10M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+90.81% upside

Дивиденти
By Dow Jones
Следващи печалби	25.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-673M 840M
Предишно отваряне	14.29
Предишно затваряне	11.5

Настроения в новините

By Acuity

100%

337 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.02.2026 г., 17:37 ч. UTC

Придобивния, сливания и поглъщания

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

21.02.2026 г., 14:31 ч. UTC

Придобивния, сливания и поглъщания

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21.02.2026 г., 05:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

20.02.2026 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20.02.2026 г., 22:12 ч. UTC

Печалби

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

20.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

20.02.2026 г., 21:23 ч. UTC

Печалби

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20.02.2026 г., 21:20 ч. UTC

Пазарно говорене

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20.02.2026 г., 21:01 ч. UTC

Придобивния, сливания и поглъщания

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20.02.2026 г., 20:38 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20.02.2026 г., 20:17 ч. UTC

Пазарно говорене

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20.02.2026 г., 20:11 ч. UTC

Пазарно говорене

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20.02.2026 г., 19:59 ч. UTC

Пазарно говорене

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20.02.2026 г., 19:58 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20.02.2026 г., 19:49 ч. UTC

Пазарно говорене

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20.02.2026 г., 19:09 ч. UTC

Пазарно говорене

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20.02.2026 г., 19:00 ч. UTC

Пазарно говорене

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20.02.2026 г., 18:28 ч. UTC

Пазарно говорене

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20.02.2026 г., 18:20 ч. UTC

Пазарно говорене

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20.02.2026 г., 18:05 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

20.02.2026 г., 18:04 ч. UTC

Пазарно говорене

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20.02.2026 г., 17:38 ч. UTC

Пазарно говорене

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20.02.2026 г., 17:24 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.02.2026 г., 17:24 ч. UTC

Пазарно говорене

Correction to Treasury Yields Fall Market Talk

20.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

20.02.2026 г., 16:53 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

20.02.2026 г., 16:53 ч. UTC

Пазарно говорене

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20.02.2026 г., 16:45 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.02.2026 г., 16:45 ч. UTC

Пазарно говорене

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

90.81% нагоре

12-месечна прогноза

Среден 22 USD 90.81%

Висок 25 USD

Нисък 18 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

337 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.